The tumor microenvironment shapes hallmarks of mature B-cell malignancies von Shain, K H, Dalton, W S, Tao, J

Volltext

An architecture for integrating planar and 3D cQED devices von Axline, C., Reagor, M., Heeres, R., Reinhold, P., Wang, C., Shain, K., Pfaff, W., Chu, Y., Frunzio, L., Schoelkopf, R. J.

Volltext

The B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignancies von Shain, K H, Tao, J

Volltext

Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma von Meads, M B, Fang, B, Mathews, L, Gemmer, J, Nong, L, Rosado-Lopez, I, Nguyen, T, Ring, J E, Matsui, W, MacLeod, A R, Pachter, J A, Hazlehurst, L A, Koomen, J M, Shain, K H

Volltext

Allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome von Nishihori, T, Komrokji, R, Shain, K, Anasetti, C

Volltext

Signatures of long-range-correlated disorder in the magnetotransport of ultrathin topological insulators von Nandi, D., Skinner, B., Lee, G. H., Huang, K.-F., Shain, K., Chang, Cui-Zu, Ou, Y., Lee, S.-P., Ward, J., Moodera, J. S., Kim, P., Halperin, B. I., Yacoby, A.

Volltext

Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria von O'Keefe, C L, Sugimori, C, Afable, M, Clemente, M, Shain, K, Araten, D J, List, A, Epling-Burnette, P K, Maciejewski, J P

Volltext

220 Overcoming drug-resistance in multiple myeloma by XPO1 inhibitor combination therapy von Turner, J, Dawson, J, Grant, S, Shain, K, Cubitt, C, Dai, Y, Zhoui, L, Kauffman, M, Shacham, S, Sullivan, D

Volltext

Allogeneic hematopoietic cell transplantation for consolidation of VGPR or CR for newly diagnosed multiple myeloma von Nishihori, T, Ochoa-Bayona, J L, Kim, J, Pidala, J, Shain, K, Baz, R, Sullivan, D, Jim, H S, Anasetti, C, Alsina, M

Volltext

IBRUTINIB FOR THE TREATMENT OF BING‐NEEL SYNDROME: A RETROSPECTIVE, MULTICENTER STUDY von Castillo, J., Itchaki, G., Paludo, J., Varettoni, M., Buske, C., Eyre, T., Chavez, J., Shain, K., Issa, S., Palomba, L., Pasvolsky, O., Simpson, D., Talaulikar, D., Tam, C., Tedeschi, A., Ansell, S., Nayak, L., Treon, S.

Volltext

High-dose melphalan produces favorable response in a patient with multiple myeloma and coexisting essential thrombocythemia with JAK2 mutation von Nishihori, T, Hassoun, Y, Zhang, L, Shain, K, Alsina, M, Kharfan-Dabaja, M A

Volltext

Logarithmic singularities and quantum oscillations in magnetically doped topological insulators von Nandi, D., Sodemann, Inti, Shain, K., Lee, G. H., Huang, K.-F., Chang, Cui-Zu, Ou, Yunbo, Lee, S. P., Ward, J., Moodera, J. S., Kim, P., Yacoby, A.

Volltext

Cell Adhesion Is a Key Determinant in de Novo Multidrug Resistance (MDR): New Targets for the Prevention of Acquired MDR von Shain, K H, Dalton, W S

Volltext

Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation von Sugimori, C, Padron, E, Caceres, G, Shain, K, Sokol, L, Zhang, L, Tiu, R, O'Keefe, C L, Afable, M, Clemente, M, Lee, J M, Maciejewski, J P, List, A F, Epling-Burnette, P K, Araten, D J

Volltext

Histone deacetylase 11 (HDAC11) is critical for plasma cell development and multiple myeloma survival von Brayer, J, Sahakian, E, Nguyen, D, Powers, J, Meads, M, Deng, S, Distler, A, Alsina, M, Nishihori, T, Baz, R, Villagra, A, Pinilla-Ibarz, J, Sotomayor, E.M, Shain, K

Volltext

Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cel... von NIU, Guilian, SHAIN, Kenneth H, MEI HUANG, RAVI, Rajani, BEDI, Atul, DALTON, William S, JOVE, Richard, HUA YU

Volltext

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells von Pardoll, Drew, Yu, Hua, Wang, Tianhong, Niu, Guilian, Kortylewski, Marcin, Burdelya, Lyudmila, Shain, Kenneth, Zhang, Shumin, Bhattacharya, Raka, Gabrilovich, Dmitry, Heller, Richard, Coppola, Domenico, Dalton, William, Jove, Richard

Volltext

Patterns of Failure in Multiple Myeloma with Extramedullary Disease Following Anti-BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy von Nakashima, J.Y., Khatri, V., Cruz-Chamorro, R.J., Zhou, J., Patra, P., Gonzalez, R., De Avila, G., Locke, F.L., Liu, H.D., Nishihori, T., Puglianini, O.C., Alsina, M., Garjales-Cruz, A., Baz, R., Shah, B.D., Shain, K., Jain, M.D., Hansen, D., Freeman, C., Figura, N.B.

Volltext

Genotypic and phenotypic comparisons of de Novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model von HAZLEHURST, Lori A, ENKEMANN, Steven A, DALTON, William S, BEAM, Craig A, ARGILAGOS, Raul F, PAINTER, Jeffrey, SHAIN, Kenneth H, SAPORTA, Sara, BOULWARE, David, MOSCINSKI, Lynn, ALSINA, Melissa

Volltext

Myeloma Cells Selected for Resistance to CD95-Mediated Apoptosis Are Not Cross-Resistant to Cytotoxic Drugs: Evidence for Independent Mechanisms of Caspase Activation von Landowski, Terry H., Shain, Kenneth H., Oshiro, Marc M., Buyuksal, Ibrahim, Painter, Jeffrey S., Dalton, William S.

Volltext